The association between serum hepcidin-25 level and subclinical atherosclerosis in peritoneal dialysis patients

Bülent Erdoğan, Barış Eser1, Özlem Yayar

  • 1Department of Nephrology, Hitit University, Erol Olcok Training and Research Hospital, Çorum, Turkey. beser374@gmail.com.

Insights

Serum hepcidin-25 is linked to inflammation and atherosclerosis markers in peritoneal dialysis patients. Higher hepcidin levels correlate with increased cardiovascular risk factors like C-reactive protein and age.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Biochemistry

Background:

  • Hepcidin is increasingly recognized as a cardiovascular marker in chronic kidney disease (CKD).
  • Understanding hepcidin's role in peritoneal dialysis (PD) patients is crucial for managing cardiovascular risk.

Purpose of the Study:

  • To investigate the relationship between serum hepcidin-25, inflammation, iron parameters, and carotid intima-media thickness (CIMT) in PD patients.
  • To explore hepcidin's potential as a marker for atherosclerosis in this population.

Main Methods:

  • A cross-sectional study included 58 PD patients.
  • Serum hepcidin-25, inflammation markers (CRP), iron parameters, and CIMT were measured.
  • Correlation and regression analyses were used to assess relationships.

Main Results:

  • Patients with high hepcidin levels showed significantly higher age, BMI, glucose, CRP, and CIMT.
  • Hepcidin positively correlated with age, dialysis duration, glucose, ferritin, CRP, and CIMT.
  • Age and CRP were independently associated with CIMT.

Conclusions:

  • Hepcidin-25 is strongly associated with age and C-reactive protein in PD patients.
  • These findings suggest hepcidin may play a role in the pathophysiology of atherosclerosis.
  • Further prospective studies are needed to confirm hepcidin's impact on atherosclerosis in PD patients.
Abstract

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
909
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
3.5K
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
920
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
553
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.5K
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
1.9K